0
Perspectives on Care at the Close of Life | Clinician's Corner

Alzheimer Disease: Title and subTitle Break"It's Okay, Mama, If You Want to Go, It's Okay"

Ann C. Hurley, RN, DNSc; Ladislav Volicer, MD, PhD
JAMA. 2002;288(18):2324-2331. doi:10.1001/jama.288.18.2324
Text Size: A A A
Published online
Perspectives on Care at the Close of Life Section Editor: Margaret A. Winker, MD, Deputy Editor, JAMA.

About 4 million people in the United States have Alzheimer disease (AD) and the number of incident cases is expected to more than double from 377 000 in 1995 to 959 000 in 2050. Patients, their families, and health care professionals struggle with a relentless and irreversible neurological syndrome that can last from 2 to 20 years. Alzheimer disease causes both cognitive and functional impairments that predispose the patient to behavioral symptoms, destroy intellectual capacity and personality, erase the ability to communicate one's wishes for care, and lead to life-threatening consequences. At the close of life, family members and clinicians face decisions regarding degrees of intensive medical care to be provided for treatment of the late-stage consequences of AD, including withdrawal of invasive interventions, initiation of hospice, and treatment of a range of progressive medical conditions. Physicians can assist patients with AD and their loved ones through the terminal phases of the illness by preparing them for the relentless progression of the disease and by supporting them through the intellectual and emotional conflicts accompanying the end of life.

Figures in this Article

Mrs R, an 80-year-old African American woman with a long history of diabetes, had Alzheimer disease (AD) for 9 years before her death. She was a junior college graduate who had worked in state government and later, according to her daughter, was the first African American manager in a major department store. At age 71 years, she was diagnosed as having AD. Within a year she required full-time supervision. One of her 2 daughters, Ms P, moved into her home. Mrs R joined a PACE program (Program for All-inclusive Care of the Elderly) and traveled daily by van to a dementia day-care program. She also received home care so her daughter could continue to work.

During the next few years she became incontinent of urine and exhibited some behavioral symptoms associated with AD, including agitation and wandering. By the sixth year after her diagnosis, she was wheelchair dependent. Around this time, the family discussed prognosis and plans with her physician and agreed that they did not want resuscitation or life-sustaining treatment. They were undecided about tube feeding. Soon after this, Mrs R was hospitalized when her leg became severely infected after a wheelchair injury. She was discharged to a skilled nursing facility, where her intake was poor despite nutritional supplements and feeding assistance at meals. She also refused or was unable to take oral medications.

While Ms P was on a short vacation, her mother became comatose in the skilled nursing facility and was hospitalized for a diabetic hyperosmolar coma. After recovery, she often refused to eat. A feeding gastrostomy tube was placed, and she returned to the skilled nursing facility. She had no complications from the feeding tube, apart from an initial undesirable weight gain, but her mental function continued to deteriorate, and she became increasingly less verbally responsive. She developed such severe flexion contractures of both her arms and legs that it was difficult to position her in a chair, which left her almost entirely bedbound. A new physician described her as being vegetative, with no purposeful responses of any kind. Her daughters continued to visit her regularly and were very attentive to her care.

Three years after placement of the feeding tube, her daughters expressed dismay at her condition but felt unable to discontinue the tube feedings. After further discussion with the physician, Mrs R's daughters placed her in a hospice program. Her feeding tube was removed, and she died comfortably, an hour after her daughters' last visit, when they had given her "permission" to do so: "It's okay, Mama, if you want to go, it's okay. We're doing fine, we love you, you can go."

Shortly after Mrs R's death, in May 2001, a Perspectives editor separately interviewed Mrs R's daughter (Ms P), and her PACE physician, Dr C.

MS P: About 8 years ago my mother was showing signs of dementia. She was in the house by herself and she was forgetting things like the utility bill or her telephone bill. She wasn't keeping the house tidy, as she would in the past. She wasn't bathing and she would put on the same clothes all the time . . . she had had tons of clothes and would take pride in wearing her outfits and keeping herself together. We didn't pick it up right off, I guess because we would always see her. Other people picked up [on it], but they didn't say anything until we took her to have an assessment done. They said that she was suffering from Alzheimer's. Her short-term memory was gone, pretty much, or it was going.

Alzheimer disease affects about 4 million people in the United States.1 The number of incident cases is expected to double from 377 000 in 1995 to 959 000 in 2050.2 Alzheimer disease is a long-term, relentlessly progressive, life-limiting, and ultimately terminal illness in which the afflicted person may live for 2 to 20 years after diagnosis.3 - 4 It is difficult to estimate when AD patients will need nursing home-type care or will die. A longitudinal study of 236 patients with AD found the need for nursing home placement was predicted by younger age at AD onset, lower cognitive test scores, shorter estimated disease duration, and presence of extrapyramidal signs or psychotic symptoms at the initial visit.5 Mortality risk was increased by extrapyramidal signs, lower cognitive test scores, shorter AD duration, and male sex.5 The most frequent immediate cause of death is a life-threatening infection such as pneumonia, usually related to risk factors of eating difficulties, immobility, and incontinence caused by functional impairment and behavioral symptoms of late stage AD.6

Among the many issues the primary care provider must address with the patient and family are the diagnosis7 and progressive nature of AD.8 Potentially life-saving safety issues such as not driving9 have to be addressed early in the course of AD. Although not an immediate safety concern, clinicians should initiate discussions about selecting a health care proxy and informing the proxy about future treatment preferences, since only in the early stage do patients have the capacity for making complex decisions.10

Preparing for Lack of Decision-Making Capacity

MS P: Well, we hadn't discussed that [care she wanted for herself if her health deteriorated and quality of life diminished] with my mother. We just didn't have that conversation. We hadn't discussed that and we really didn't discuss her quality of life, where we'd want it to end if it got to that point. Which I really regret 'cause . . . if we would have talked about it, my mother and I, it probably wouldn't have lasted this long for all of us.

Clinicians should use the time soon after diagnosis to learn the patient's wishes for future treatment modalities and willingness to discuss these issues and make these choices. Without having ongoing discussions, future care may be provided based on caregivers' views11 instead of patients' expressed preferences or wishes derived from known values. Educated decision making should be established and maintained throughout the progressive course, with the roles changing from the early stage when patients can represent themselves to later stages when the proxy presents the patient's wishes.12

Mrs R's family regretted they had not talked about these issues with their mother.

Many families are unfamiliar with the dying process of a person with terminal AD and are thrust into the role of proxy decision maker. Families need support from their professional caregivers as they make and live through some of the most difficult decisions of their lives—selecting life-prolonging treatments that may also increase discomfort, or choosing care that would provide comfort but may be seen as hastening death.13 - 14

Preparing for Progressive Decline

The progression of AD can be characterized by 4 phases15 forming a sigmoidal curve.16 We17 have presented a simplified depiction of AD progression (Figure 1) divided into 4 stages defined by the Clinical Dementia Rating Scale18 that has been expanded further by Dooneief et al.19 For simplicity, severe and profoundly demented stages were combined. Health teaching should target the patient's current problems and those likely to occur soon and for which caregivers should be prepared.

Figure. Progressive Decline Observed in Alzheimer Disease
Grahic Jump Location
Reprinted with permission from Volicer and Hurley.17
Community Care

More than 70% of Americans with AD live at home4 receiving community-based care. Counseling and support programs for spouse caregivers can delay nursing home placement for elders with AD.20 An intervention of 6 sessions of family counseling, including joining a support group, and having access to counselors resulted in almost 1 additional year in the community before nursing home placement.21 When frail older patients cared for by physicians in their homes selected their preference for a specific place of death, plans were successful in 91%22 ; however, we could identify no similar studies for patients with AD. Providing physician care at home may improve end-of-life care for older persons.22 - 23

The Move to a Nursing Home

MS P: It was getting to be too much: rushing home, even though we had care, considering . . . her diabetes, her high blood pressure, her walking out. So we made the decision [that she would be placed in a nursing home].

There often comes a time when the family has to relinquish home care because of inability to manage problematic patient behaviors24 or because they lack the resources to provide 24-hour a day care25 and must seek institutionalized care. Smith et al26 found that during 3600 person-years of surveillance, 203 (40%) of 512 AD patients were placed in nursing homes.26 In a study of 5788 community-residing elders with AD and their caregivers, Yaffe and colleagues27 found that both patient and caregiver characteristics independently predicted nursing home placement. Patient predictors included living alone, being white, having cognitive and functional impairment, and having behavioral problems. Caregiver predictors included older age and higher caregiver burden.27

Caregiving costs are enormous. Family caregiving can distress and disable caregivers causing intense physical, emotional, and financial burden, yet families provide unpaid care for AD valued at $65 billion per year28 of the at least $100 billion spent by all sectors of US society.4 Annual per patient costs of informal care are estimated to range from $10 400 to $34 517.29 Medicare expenses for persons with AD are 70% higher than for other beneficiaries.30 Because nursing home admissions for persons with AD are almost twice as long as for the average beneficiary, when Medicaid pays for long-term care, the cost is about $7700 more for persons with AD.31

Deciding to place a patient in a nursing home carries dual concerns of finding an appropriate facility and managing the guilt of giving up primary caregiver responsibilities.32 The family selects the nursing home. The physician can help the family in this process by providing a list of questions to ask when visiting potential nursing homes, such as those listed in the Box, which are suggested by our clinical experience.

After transferring the patient, family caregivers should have emotional support to help them cope with their own sense of "failing" the patient. Physicians and other health care professionals should be willing to help family members deal with their guilt, depression, and grief.33 At this juncture, symptoms of grieving seem to cycle around 2 losses: admitting a loved one to long-term care and needing to make an advance care plan for the end of life.33 - 34 The physician can help provide reassurance: "You have done such a fine job of caregiving. Look at the nursing home staff. It takes a team of nurses working 3 shifts a day, 7 days a week to do what you have been doing." The physician should also reiterate that no matter how fine the nursing home care is, the disease will progress relentlessly, the patient's condition will continue to worsen,8 and the patient will ultimately die either from a consequence of AD or from another illness.

Nutrition and Hydration

DR C: Right after she got into the nursing home they noted she had a lot of difficulty eating. She would push food away or refuse to swallow it. At that time the family discussed goals of care with the physician: a do not resuscitate order, do not intubate, no CPR [cardiopulmonary resuscitation]—comfort type of care—but they were undecided about a feeding tube. Not long after that, as the daughter arrived home from a vacation, her mother was admitted to the hospital in a comatose state (hyperosmolar coma). When she regained alertness, the feeding problems persisted. A gastrostomy took place during the hospitalization. Then she went back to the nursing home with the gastrostomy [and] initially had a weight gain that was undesirable.

MS P: We talked to the doctors and they said, "We can't feed her, she's resistant, and not only that her swallowing mechanisms are off." That's when we decided to use the feeder, the tube.

Use of a Feeding Tube

An important goal of care for AD patients is to provide adequate nutrition by promoting eating and preventing food refusal. Those caring for the patient must have time for, and the system must support, the individual needs of patients who initially refuse food.35 It takes time to sit and make eye contact, chat, and make eating a pleasurable experience, yet it is one of the most important components of nursing home care.36 Patients use many behaviors to refuse food. In a study of eating difficulties of patients with severe AD, 36 (51%) of 71 residents refused food.37 During attempts at feeding, 89% of these turned their heads away when food was offered; 78% kept their mouths shut; 72% pushed the spoon or hand away; and 39% spit out food. However, all these patients were eventually successfully fed by hand, and their mortality rate was not different from patients who did not refuse food.37 Unfortunately, feeding tubes are often inserted in acute care settings if a patient has even mild eating difficulties.

Food refusal may be an unrecognized symptom of depression, which may be precipitated by admission to a nursing home.38 Patients who refuse food often respond well to antidepressant therapy, even those with advanced dementia.39

Tube feeding might have been indicated shortly after Mrs R's diabetic coma, when her consciousness was impaired, but later her eating ability should have been reevaluated. Because there was no discussion between the physician and the family, the default decision was made to maintain permanent tube feeding. Although such discussions are not easy, it is incumbent on the physician to initiate the dialogue and involve the interdisciplinary team. The videotape Alzheimer's Disease: The Family Conference illustrates how this may be accomplished (see Other Resources at http://www.jama.com). Natural feeding should be resumed as soon as the medical crisis passes.

Even patients with a progressive dementia can revert to natural feeding after tube feeding.40 An interdisciplinary team, including a nurse, dietitian, and physician should develop an individualized plan based on the patient's target body weight and functional eating abilities.41 Natural feeding can begin while the tube is in place, facilitating both types of feeding until the patient's eating is re-established. Then the tube may be removed. A program of functional feeding using the patient's remaining skills combined with skillful hand feeding should be initiated.42 The caregiver may place his/her hand over the patient's hand, place a small amount of sweetened food, such as applesauce, on the tip of a large spoon, move it to the patient's mouth, and place the tip between the patient's lips to stimulate eating.35

Permanent tube feeding is not recommended for persons with advanced dementia,40 even those who choke on food and liquids.37 ,42 In advanced AD, tube feeding does not prevent aspiration, improve functioning or quality of life, increase comfort, or promote weight gain.43 Meier et al44 found hospitalized AD patients had a 50% chance of dying in 6 months, with or without a feeding tube. Although use of a feeding tube may have advantages for others to save staff time or decrease fear of regulatory complaints for undernutrition, it also has many disadvantages for the patient, including decreased pleasure from eating, less human contact, and, frequently, the need to use restraints to prevent the patient from removing the tube.35

Removing Feeding Tubes

MS P: The last year, it started being painful for me to go and visit. At Easter, when we went out we started crying and said, "We can't do this anymore, not for us, or for her." So we made the decision to remove the tube.

DR C: They had actually gone to visit the [city's nursing home hospice] on their own . . . [and] they spoke with the hospice director. He was very compelling about cessation of tube feeding. He said years ago we didn't have feeding tubes and the natural way [to feed dying] people was [to give] sips of soup, and then just mouth care, and not have feeding tubes. After talking with him about simply discontinuing the feeding tube they felt comfortable and were fortunately able to get her into that setting.

After 4 years of tube feeding, it may have been considered natural for Mrs R to continue receiving food by a tube. However, one of several widely held misconceptions about feeding, is that it is "ordinary care like spoon feeding." Except for providing a means to administer calories and fluids, tube feeding is not like natural eating or drinking.45 Tube feeding rates vary widely by state,46 suggesting that variables other than patient needs are the primary determinants. Despite the data, physicians, nursing care staff, and family members must deal with decisions to withdraw therapy that is still considered life-sustaining, and ultimately allow the person to die of natural causes.

Many health care professionals lack knowledge about artificial nutrition and hydration at the end of life and may convey inaccurate or misleading information to patients and their families.47 Family members may fear that the patient will starve to death if she/he stops being fed, but patients who are cognitively intact and dying report that they often do not feel thirsty or hungry. In a study of 32 mentally aware patients with terminal illness, monitored on a comfort care unit until death,48 20 never experienced hunger and 11 experienced hunger only initially. Twenty patients never experienced thirst or only initially. Body functions are shutting down during the dying process and food and liquids are no longer necessary.49 In fact, decreased hydration is beneficial during the dying process because dehydration decreases the sensation of pain and prevents edema and excessive respiratory secretions. Dehydration also decreases the incidence of vomiting and diarrhea. The only consequence of dehydration that may lead to discomfort for dying patients is dryness of the mouth, lips or eyes, which can be prevented or alleviated by moisturizing spray, swabs, ice chips, or lubricating eye drops.49

The Family's Emotional and Intellectual Conflict During Disease Progression

MS P: Two years ago, it got to the point where she would be lying there. They would move her from side to side and get her in the reclining wheelchair. She was getting bedsores. I had problems with [the nursing home staff], insofar as making sure they moved her, making sure they got her up, making sure they did her hygiene. It was almost like she was just a vegetable. Every now and then she would mumble something but it wasn't recognizable. We all had our feelings, I thought, "Oh God, you know, maybe I wish she would just go, I wish God would just take her." And then I would think, "Oh but that's a horrible thought." But I was being honest with myself. I didn't share it with my sister, and I'm sure she was thinking the same thing. At night I would wait for the phone, it was always in the back of my mind, maybe she had a heart attack, or maybe she's just gone to sleep and didn't wake up. That didn't happen.

The feelings expressed by Mrs R's daughters are common. Mrs R went from being wheelchair mobile, to a reclining wheelchair, to being bedbound with pressure ulcers. These decrements can be viewed as a series of crises, each one representing a "little death." Analysis of data from support groups revealed that loved ones are described as "the walking dead" early in the course of the disease because, at best, only remnants remain of the unique persons they once were.50

Families grieve over decrements in functional ability, inability to interact in a meaningful way, and the loss of the very personhood of the patient. It is important to be aware of the multidimensional aspects of grieving, its extended duration, and potential sequelae of unresolved grieving—depression, illness, lack of self-care, and social isolation.51 As Brown et al52 (p39) noted,

An important aspect of family support is acknowledgment that the wish for the victim's death may be the ultimate expression of love as well as a wish for relief from the pain of observing its process. Families must be helped to anticipate death and learn to live with the mixture of joy and rage at the prolongation of the dying process. Grief and mourning seem never ending.

As the disease progresses, there is a period of accelerated mourning52 and a definite need for bereavement services,53 but regrettably, very few nursing homes use the services of bereavement counselors.54

Treatment of medical problems and other co-morbid conditions should weigh possible benefits against the burdens imposed by treatment. Treatment burdens are increased because the patient does not understand the rationale for medical interventions and may actively oppose them. Treatment benefits are decreased in dementia because of decreased treatment effectiveness and reduced life expectancy.55 Another factor to consider is the inability of patients to report adverse effects of treatment. Therefore, long-term illnesses, such as hypertension and diabetes, should be treated conservatively with the goals of reducing short-term complications of the disease and preventing consequences of overtreatment, such as dizziness resulting in falls and hypoglycemic episodes.

Treatment of cognitive impairment is an unrealistic goal in severe dementia. Cholinesterase inhibitors such as donepezil56 may produce modest improvements in patients with mild or moderate AD, characterized as a Mini-Mental State Examination score57 between 10 and 24.58 There is no evidence that cholinesterase inhibitors would be effective in patients with severe AD. Similarly, treatment with vitamin E delayed loss of function but not death in patients with moderate AD.59 Estrogen replacement therapy does not appear to slow the progression of AD or improve global, cognitive, or functional outcomes in women with mild to moderate AD.60 Since estrogen also does not appear to reduce coronary heart disease events,61 there is no evidence to support estrogen treatment of women with AD.

Treating Infections

Infections are a common consequence of advanced dementia because of changes in immune function, incontinence, decreased mobility, and aspiration.6 Oral antibiotic treatment of infections in AD is preferred over parenteral antibiotics because oral antibiotics are at least equally effective62 - 63 and do not require restraints to prevent removal of an intravenous catheter. Intramuscular administration of cephalosporins offers a reasonable alternative in patients with poor oral intake.64 Hospitalization for pneumonia not only does not improve the outcome in nursing home patients but actually results in more frequent death and functional deterioration.65

The effectiveness of antibiotic treatment is diminished in the terminal stage of AD when infections become recurrent. Antibiotic treatment did not extend survival in cognitively impaired patients who were unable to ambulate and who were mute.66 Similarly, Luchins et al67 found no significant difference in survival rates between patients with advanced dementia who were treated with antibiotics and those who were not. Pneumonia is the most common cause of death in persons with dementia,68 reflecting the limited effectiveness of antibiotic therapy in this patient population. Antibiotics are not necessary to maintain comfort of the patient during an infectious episode because comfort can be maintained by administration of analgesics and antipyretics,69 and antibiotic administration does not affect AD progression.70

Treating Other Chronic Conditions

For patients with advanced dementia and other long-term conditions, physicians should take a conservative treatment approach that prevents or alleviates uncomfortable symptoms. The goal for AD patients nearing the end of their lives should be symptom rather than disease management. Inadequate pain management is a problem in end-of-life care in general71 and in nursing homes in particular.72 - 73 It is a serious problem for persons with AD because they cannot report symptoms74 - 76 and may exhibit atypical pain symptoms such as changes in behavior.77 Pain assessment in cognitively impaired elders may include observation of facial expression, vocalization, body movements, and changes in interpersonal interactions, activity patterns, and mental status.78 Successful management of both pain and behavioral symptoms is critical for patients with advanced AD.

Elders with AD are often excluded from pain studies.79 However, using a protocol to assess discomfort has been shown to increase use of scheduled analgesics and nonpharmacologic comfort interventions.79 In a follow-up study, when an analgesic was administered, 84% showed improved symptoms.80 Because of atypical expression of pain symptoms by elders with advanced AD, Kovach81 suggests liberal use of acetaminophen as an early approach to managing behavioral problems by treating potentially unrecognized pain.

Undertreated or untreated behavioral symptoms of dementia can cause the patient needless discomfort and are as important to relieve as pain in cancer.82 The physician should consider the context of the symptom and suggest treatment targeting the origin whenever possible.83 Nonpharmacologic strategies generally should be tried and evaluated before medications. If medications are used, they are used for the sole purpose of providing comfort to the patient, which follows the geriatric principle of "start low and go slow."

Engaging Hospice

MS P: Dr C immediately mentioned hospice care provided at the convalescent home. We were against [having it there]. Then there was a long waiting period, maybe 2 weeks, because Dr C was trying to locate a hospice. The hospice programs that she had initially contacted weren't able to take my mother because she had an open foot sore.

DR C: After offering hospice, I found it extraordinarily difficult to achieve. We considered several options, including the option of taking her home, which initially one of the sisters liked. And then she got some advice that this would be really too stressful for her. There are 3 resident hospices in the city, 1 associated with the city health services and 2 freestanding ones. But the stumbling block for [admitting her to 1 of the hospices] turned out to be the skin breakdown. They have a community care license and cannot have more than a stage-2 skin lesion in the facility. The other freestanding hospice would not consider her because she was not interactive and they wanted the patient to be able to participate in the community. The third option was the city's nursing home hospice.

Despite long-standing recommendations,84 the number of patients with advanced dementia enrolled in hospice programs is small. A survey of hospice programs showed that fewer than 1% of hospice patients had a primary diagnosis of dementia and 7% had dementia as a secondary diagnosis in addition to cancer.85 A study of 45 AD caregivers found that while 84% knew of hospice, only 11% had considered hospice as an option for their care recipient.86 In addition to the barriers identified by Dr C, it is difficult to predict whether a patient with AD will die within 6 months. Although it is relatively easy to predict which patients will not die within 6 months because their dementia is not advanced, for the remaining patients the probability of dying is still only about 50%.87

The National Hospice Organization published guidelines for inclusion of demented individuals in hospice programs.88 However, these guidelines are not based on actual data, some of the criteria are vague, and they are better at predicting who will not die within 6 months than those who will die. Additionally, almost half of the patients could not be rated by these criteria because their disease symptoms did not proceed in the expected order.67 Predicting 6-month survival is difficult because the death of AD patients is often caused by infections6 and other unpredictable complications. However, once enrolled in a Medicare-certified hospice program, the patient may remain beyond 6 months as long as continued decline is documented. The physician also needs to help the family understand the unpredictability of death.

Effective and reliable end-of-life care for persons with AD and other conditions with a slowly dwindling course to death requires compassionate and skillful clinicians and changes in the organization and financing of care to match these trajectories.89 Instead of linking reimbursable health care services to limited prognosis, severity of illness and the expectation of declining status should trigger the initiation of tailored services.90

Although caring for patients with AD can be challenging and involves many difficult decisions, good endings are possible. By encouraging patient discussions regarding care preferences early in the course of the disease and educating family and caregivers about what to expect and how to deal with each stage of the disease, physicians can ease the transition for patients and families. Patients with advanced dementia should receive end-of-life care focused on maximizing the patient's comfort rather than prolonging life.

Hurley AC, Wells N. Past, present, and future directions for Alzheimer research.  Alzheimer Dis Assoc Disord.1999;13(suppl 1):S6-S10.
Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.  Alzheimer Dis Assoc Disord.2001;15:169-173.
National Institute on Aging.  2000 Progress Report on Alzheimer's Disease. Silver Spring, Md: National Institutes on Health; 2000.
Alzheimer's Association.  Statistics about Alzheimer's Disease; 2002. Available at: http://www.alzheimers.org. Accessed August 8, 2002.
Stern Y, Tang MX, Albert MS.  et al.  Predicting time to nursing home care and death in individuals with Alzheimer disease.  JAMA.1997;277:806-812.
Volicer L, Brandeis GH, Hurley AC. Infections in advanced dementia. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:29-47.
Drickamer MA, Lachs MS. Should patients with Alzheimer's disease be told their diagnosis.  N Engl J Med.1992;326:947-951.
Hurley A, Volicer L, Mahoney E. Progression of Alzheimer's disease and symptom management.  Federal Practitioner.1996;13(suppl):16-22.
Berger JT, Rosner F. Ethical challenges posed by dementia and driving.  J Clin Ethics.2000;11:304-308.
Rempusheski VF, Hurley AC. Advance directives and dementia.  J Gerontol Nurs.2000;26:27-34.
Karlawish JH, Quill T, Meier DE.for the American College of Physicians-American Society of Internal Medicine Consensus Panel.  A consensus-based approach to providing palliative care to patients who lack decision-making capacity.  Ann Intern Med.1999;130:835-840.
Blasi ZV, Hurley AC, Volicer L. End-of-life care in dementia: problems and prospects.  J Am Med Directors Assoc.2002;13:57-65.
Robinson EM, Hurley AC, Volicer L. Advanced proxy planning in patients who become incompetent.  Federal Practitioner.1998;15:26-42.
Robinson EM. Wives' struggle in living through treatment decisions for husbands with advanced Alzheimer's disease.  J Nursing Law.2000;7:21-39.
Helmes E, Merskey H, Fox H, Fry RN, Bowler JV, Hachinski VC. Patterns of deterioration in senile dementia of the Alzheimer type.  Arch Neurol.1995;52:306-310.
Doody RS, Massman PJ, Dunn JK. A method for estimating progression rates in Alzheimer disease.  Arch Neurol.2001;58:449-454.
Volicer L, Hurley AC. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer; 1998.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia.  Br J Psychiatry.1982;140:566-572.
Dooneief G, Marder K, Tang MX, Stern Y. The clinical dementia rating scale: community-based validation of "profound" and "terminal" stages.  Neurology.1996;46:1746-1749.
Mittelman MS, Ferris SH, Steinberg G.  et al.  An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers.  Gerontologist.1993;33:730-740.
Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer disease: a randomized controlled trial.  JAMA.1996;276:1725-1731.
Leff B, Kaffenbarger KP, Remsburg R. Prevalence, effectiveness, and predictors of planning the place of death among older persons followed in community-based long term care.  J Am Geriatr Soc.2000;48:943-948.
Leff B, Burton JR. The future history of home care and physician house calls in the United States.  J Gerontol A Biol Sci Med Sci.2001;56:M603-M608.
Spector WD, Fleishman JA, Pezzin LE, Spillman BC. The Characteristics of Long-Term Care Users. Washington, DC: US Dept of Health and Human Services; 2000.
Gaugler JE, Edwards AB, Femia EE.  et al.  Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement.  J Gerontol B Psychol Sci Soc Sci.2000;55:P247-P255.
Smith GE, O'Brien PC, Ivnik RJ, Kokmen E, Tangalos EG. Prospective analysis of risk factors for nursing home placement of dementia patients.  Neurology.2001;57:1467-1473.
Yaffe K, Fox P, Newcomer R.  et al.  Patient and caregiver characteristics and nursing home placement in patients with dementia.  JAMA.2002;287:2090-2097.
McConnell S, Riggs J. The policy challenge of Alzheimer's disease.  Generations.1999;23:69-74.
Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.  Am J Manag Care.2001;7:809-818.
Eppis L, Poisal JA. Mental health of medical beneficiaries: 1995.  Home Care Financ Rev.Fall 1999:207-210.
Menzin J, Lang K, Friedman M, Neumann P, Cummings JL. The economic cost of Alzheimer's disease and related dementias to California Medicaid program ("Medi-Cal") in 1995.  Am J Geriatr Psychiatry.1999;7:300-308.
Ryan AA, Scullion HF. Nursing home placement: an exploration of the experiences of family carers.  J Adv Nurs.2000;32:1187-1195.
Mahoney M. Family Decision Making for Advanced Alzheimer Patients [dissertation]. Boston, Mass: Boston College School of Nursing; 1992.
Mahoney MA, Hurley A, Volicer L. Advance proxy planning. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:169-188.
Mahoney EK, Volicer L, Hurley AC. Food refusal. In: Mahoney EK, Volicer L, Hurley AC, eds. Management of Challenging Behaviors in Dementia. Baltimore, Md: Health Professions Press Inc; 2000:155-170.
Kayser-Jones J. Mealtime in nursing homes: the importance of individualized care.  J Gerontol Nurs.1996;22:26-31; quiz 51.
Volicer L, Seltzer B, Rheaume Y.  et al.  Eating difficulties in patients with probable dementia of the Alzheimer type.  J Geriatr Psychiatry Neurol.1989;2:188-195.
Rovner BW, Steele CD, German PS, Clark R, Folstein MF. Psychiatric diagnosis and uncooperative behavior in nursing homes.  J Geriatr Psychiatry Neurol.1992;5:102-105.
Volicer L, Rheaume Y, Cyr D. Treatment of depression in advanced Alzheimer's disease using sertraline.  J Geriatr Psychiatry Neurol.1994;7:227-229.
Volicer L, Rheaume Y, Riley ME, Karner J, Glennon M. Discontinuation of tube feeding in patients with dementia of the Alzheimer type.  Am J Alzheimer Care Relat Disord Res.1990;5:22-25.
Warden VJ. Waste not, want not.  Geriatr Nurs.1989;10:210-211.
Frisoni GB, Franzoni S, Bellelli G, Morris J, Warden V. Overcoming eating difficulties in the severely demented. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer; 1998:48-67.
Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence.  JAMA.1999;282:1365-1370.
Meier DE, Ahronheim JC, Morris J, Baskin-Lyons S, Morrison RS. High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding.  Arch Intern Med.2001;161:594-599.
Ahronheim JC. Nutrition and hydration in the terminal patient.  Clin Geriatr Med.1996;12:379-391.
Teno JM, Mor V, DeSilva D, Kabumoto G, Roy J, Wetle T. Use of feeding tubes in nursing home residents with severe cognitive impairment [letter].  JAMA.2002;287:3211-3212.
Huang ZB, Ahronheim JC. Nutrition and hydration in terminally ill patients: an update.  Clin Geriatr Med.2000;16:313-315.
McCann R, Hall W, Groth-Juncker A. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration.  JAMA.1994;272:1263-1266.
Smith SJ. Providing palliative care for the terminal Alzheimer patient. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:247-256.
Rheaume EL, Brown J. Complexities of the grieving process in spouses of patients with Alzheimer's disease. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:189-204.
Pan CX, Meier DE. Clinical aspects of end-of-life care. In: Lawton MP, ed. Annual Review of Gerontology and Geriatrics. Focus on the End of Life: Scientific and Social Issues. New York, NY: Springer Publishing Co Inc; 2000:273-308.
Brown J, Lyon PC, Sellers TD. Caring for the family caregivers. In: Volicer L, Fabiszewski KJ, Rheaume YL, Lasch KE, eds. Clinical Management of Alzheimer's Disease. Rockville, Md: Royal Tunbridge: Aspen Publishers Inc; 1988:29-41.
Moss MS. End of life in nursing homes. In: Lawton MP, ed. Annual Review of Gerontology and Geriatrics. Focus on the End of Life: Scientific and Social Issues. New York, NY: Springer Publishing Co Inc; 2000:224-258.
Komaromy C, Sidell M, Katz JT. The quality of terminal care in residential and nursing homes.  Int J Palliat Nurs.2000;6:192-200.
Wolfson C, Wolfson DB, Asgharian M.  et al.  A reevaluation of the duration of survival after the onset of dementia.  N Engl J Med.2001;344:1111-1116.
Birks JS, Melzer D, Beppu H. Donepezil for mild and moderate Alzheimer's disease [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1997:issue 2.
Folstein M, Folstein S, McHugh PJ. "Mini-Mental State": a practical method for grading the cognitive state of patients for clinicians.  J Psychiatr Res.1975;12:189-198.
Not Available.  Reference Physician's Desk.  56th ed. Montvale, NJ: Medical Economics Co Inc; 2002.
Sano M, Ernesto C, Thomas RG.  et al.  A controlled trial of selegiline, alpa-tocopherol, or both as treatment for Alzheimer's disease.  N Engl J Med.1997;336:1216-1222.
Mulnard RA, Cotman CW, Kawas C.  et al.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.  JAMA.2000;283:1007-1015. [published correction appears in JAMA. 2000;284:2597].
Writing Group for the Women's Health Initiative Investigators.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.  JAMA.2002;288:321-333.
Hirata-Dulas CA, Stein DJ, Guay DR, Gruninger RP, Peterson PK. A randomized study of ciprofloxacin vs ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.  J Am Geriatr Soc.1991;39:1040-1041.
Ostbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia: a 5-year follow-up.  Neurology.1999;53:521-526.
Thompson RS, Hall NK, Szpiech M, Reisenberg LA. Treatments and outcomes of nursing-home-acquired pneumonia.  J Am Board Fam Pract.1997;10:82-87.
Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer.  J Am Geriatr Soc.1997;45:302-306.
Fabiszewski KJ, Volicer BJ, Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients.  JAMA.1990;263:3168-3172.
Luchins DJ, Hanrahan P, Murphy K. Criteria for enrolling dementia patients in hospice.  J Am Geriatr Soc.1997;45:1054-1059.
Kukull WA, Brenner DE, Speck CE.  et al.  Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death.  J Am Geriatr Soc.1994;42:723-726.
Hurley AC, Volicer BJ, Mahoney MA, Volicer L. Palliative fever management in Alzheimer patients: quality plus fiscal responsibility.  ANS Adv Nurs Sci.1993;16:21-32.
Hurley AC, Volicer B, Volicer L. Effect of fever management strategy on the progression of dementia of the Alzheimer type.  Alzheimer Dis Assoc Disord.1996;10:5-10.
Field MJ, Cassel CK. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997.
Parmelee PA, Smith B, Katz IR. Pain complaints and cognitive status among elderly institution residents.  J Am Geriatr Soc.1993;41:517-522.
Teno J, Weizman S, Wetle T, Mor V. Persistent pain in nursing home residents [letter].  JAMA.2001;285:2081.
Benedetti F, Vighetti S, Ricco C.  et al.  Pain threshold and tolerance in Alzheimer's disease.  Pain.1999;80:377-382.
Cook AK, Niven CA, Downs MG. Assessing the pain of people with cognitive impairment.  Int J Geriatr Psychiatry.1999;14:421-425.
Hurley AC, Volicer BJ, Hanrahan P, Houde S, Volicer L. Assessment of discomfort in advanced Alzheimer patients.  Res Nurs Health.1992;15:369-377.
Wilson SA, Kovach CR, Stearns SA. Hospice concepts in the care for end-stage dementia.  Geriatr Nurs.1996;17:6-10.
American Geriatric Society Panel on Persistent Pain in Older Persons.  The management of persistent pain in older persons.  J Am Geriatr Soc.2002;50(suppl):S205-S224.
Kovach CR, Weissman DE, Griffie J, Matson S, Muchka S. Assessment and treatment of discomfort for people with late-stage dementia.  J Pain Symptom Manage.1999;18:412-419.
Kovach CR, Noonan PE, Griffie J, Muchka S, Weissman DE. Use of the assessment of discomfort in dementia protocol.  Appl Nurs Res.2001;14:193-200.
Kovach CR. Effects of hospice interventions on nursing home residents with later stages of dementia. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:276-293.
Volicer L, Hurley A, Mahoney E. Psychopharmacology and late-stage dementia behaviors. In: Kovach CR, ed. Late-Stage Dementia Care: A Basic Guide. Bristol, Pa: Taylor & Francis; 1996:125-134.
Mahoney EK, Volicer L, Hurley AC. Management of Challenging Behaviors in Dementia. Baltimore, Md: Health Professions Press Inc; 2000.
Volicer L, Rheaume Y, Brown J, Fabiszewski KJ, Brady RJ. Hospice approach to the treatment of patients with advanced dementia of the Alzheimer type.  JAMA.1986;256:2210-2213.
Hanrahan P, Luchins DJ. Access to hospice care for end-stage dementia patients: a national survey of hospice programs.  J Am Geriatr Soc.1995;43:56-59.
Casarett D, Takesaka J, Karlawish J, Hirschman KB, Clark CM. How should clinicians discuss hospice for patients with dementia? anticipating caregivers' preconceptions and meeting their information needs.  Alzheimer Dis Assoc Disord.2002;16:116-122.
Volicer BJ, Hurley AC, Fabiszewski KJ, Montgomery P, Volicer L. Predicting short-term survival for patients with advanced Alzheimer's disease.  J Am Geriatr Soc.1993;41:535-540.
Stuart B, Herbst L, Kinbrunner B.  et al.  Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. Arlington, Va: National Hospice Organization; 1995.
Lynn J. Serving patients who may die soon and their families: the role of hospice and other services.  JAMA.2001;285:925-932.
Lynn J, Wilkinson A, Etherledge L. Financing of care for fatal chronic disease: opportunities for Medicare reform.  West J Med.2001;175:299-302.

First Page Preview

First page PDF preview

Figures

Figure. Progressive Decline Observed in Alzheimer Disease
Grahic Jump Location
Reprinted with permission from Volicer and Hurley.17

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Hurley AC, Wells N. Past, present, and future directions for Alzheimer research.  Alzheimer Dis Assoc Disord.1999;13(suppl 1):S6-S10.
Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.  Alzheimer Dis Assoc Disord.2001;15:169-173.
National Institute on Aging.  2000 Progress Report on Alzheimer's Disease. Silver Spring, Md: National Institutes on Health; 2000.
Alzheimer's Association.  Statistics about Alzheimer's Disease; 2002. Available at: http://www.alzheimers.org. Accessed August 8, 2002.
Stern Y, Tang MX, Albert MS.  et al.  Predicting time to nursing home care and death in individuals with Alzheimer disease.  JAMA.1997;277:806-812.
Volicer L, Brandeis GH, Hurley AC. Infections in advanced dementia. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:29-47.
Drickamer MA, Lachs MS. Should patients with Alzheimer's disease be told their diagnosis.  N Engl J Med.1992;326:947-951.
Hurley A, Volicer L, Mahoney E. Progression of Alzheimer's disease and symptom management.  Federal Practitioner.1996;13(suppl):16-22.
Berger JT, Rosner F. Ethical challenges posed by dementia and driving.  J Clin Ethics.2000;11:304-308.
Rempusheski VF, Hurley AC. Advance directives and dementia.  J Gerontol Nurs.2000;26:27-34.
Karlawish JH, Quill T, Meier DE.for the American College of Physicians-American Society of Internal Medicine Consensus Panel.  A consensus-based approach to providing palliative care to patients who lack decision-making capacity.  Ann Intern Med.1999;130:835-840.
Blasi ZV, Hurley AC, Volicer L. End-of-life care in dementia: problems and prospects.  J Am Med Directors Assoc.2002;13:57-65.
Robinson EM, Hurley AC, Volicer L. Advanced proxy planning in patients who become incompetent.  Federal Practitioner.1998;15:26-42.
Robinson EM. Wives' struggle in living through treatment decisions for husbands with advanced Alzheimer's disease.  J Nursing Law.2000;7:21-39.
Helmes E, Merskey H, Fox H, Fry RN, Bowler JV, Hachinski VC. Patterns of deterioration in senile dementia of the Alzheimer type.  Arch Neurol.1995;52:306-310.
Doody RS, Massman PJ, Dunn JK. A method for estimating progression rates in Alzheimer disease.  Arch Neurol.2001;58:449-454.
Volicer L, Hurley AC. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer; 1998.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia.  Br J Psychiatry.1982;140:566-572.
Dooneief G, Marder K, Tang MX, Stern Y. The clinical dementia rating scale: community-based validation of "profound" and "terminal" stages.  Neurology.1996;46:1746-1749.
Mittelman MS, Ferris SH, Steinberg G.  et al.  An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers.  Gerontologist.1993;33:730-740.
Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer disease: a randomized controlled trial.  JAMA.1996;276:1725-1731.
Leff B, Kaffenbarger KP, Remsburg R. Prevalence, effectiveness, and predictors of planning the place of death among older persons followed in community-based long term care.  J Am Geriatr Soc.2000;48:943-948.
Leff B, Burton JR. The future history of home care and physician house calls in the United States.  J Gerontol A Biol Sci Med Sci.2001;56:M603-M608.
Spector WD, Fleishman JA, Pezzin LE, Spillman BC. The Characteristics of Long-Term Care Users. Washington, DC: US Dept of Health and Human Services; 2000.
Gaugler JE, Edwards AB, Femia EE.  et al.  Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement.  J Gerontol B Psychol Sci Soc Sci.2000;55:P247-P255.
Smith GE, O'Brien PC, Ivnik RJ, Kokmen E, Tangalos EG. Prospective analysis of risk factors for nursing home placement of dementia patients.  Neurology.2001;57:1467-1473.
Yaffe K, Fox P, Newcomer R.  et al.  Patient and caregiver characteristics and nursing home placement in patients with dementia.  JAMA.2002;287:2090-2097.
McConnell S, Riggs J. The policy challenge of Alzheimer's disease.  Generations.1999;23:69-74.
Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.  Am J Manag Care.2001;7:809-818.
Eppis L, Poisal JA. Mental health of medical beneficiaries: 1995.  Home Care Financ Rev.Fall 1999:207-210.
Menzin J, Lang K, Friedman M, Neumann P, Cummings JL. The economic cost of Alzheimer's disease and related dementias to California Medicaid program ("Medi-Cal") in 1995.  Am J Geriatr Psychiatry.1999;7:300-308.
Ryan AA, Scullion HF. Nursing home placement: an exploration of the experiences of family carers.  J Adv Nurs.2000;32:1187-1195.
Mahoney M. Family Decision Making for Advanced Alzheimer Patients [dissertation]. Boston, Mass: Boston College School of Nursing; 1992.
Mahoney MA, Hurley A, Volicer L. Advance proxy planning. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:169-188.
Mahoney EK, Volicer L, Hurley AC. Food refusal. In: Mahoney EK, Volicer L, Hurley AC, eds. Management of Challenging Behaviors in Dementia. Baltimore, Md: Health Professions Press Inc; 2000:155-170.
Kayser-Jones J. Mealtime in nursing homes: the importance of individualized care.  J Gerontol Nurs.1996;22:26-31; quiz 51.
Volicer L, Seltzer B, Rheaume Y.  et al.  Eating difficulties in patients with probable dementia of the Alzheimer type.  J Geriatr Psychiatry Neurol.1989;2:188-195.
Rovner BW, Steele CD, German PS, Clark R, Folstein MF. Psychiatric diagnosis and uncooperative behavior in nursing homes.  J Geriatr Psychiatry Neurol.1992;5:102-105.
Volicer L, Rheaume Y, Cyr D. Treatment of depression in advanced Alzheimer's disease using sertraline.  J Geriatr Psychiatry Neurol.1994;7:227-229.
Volicer L, Rheaume Y, Riley ME, Karner J, Glennon M. Discontinuation of tube feeding in patients with dementia of the Alzheimer type.  Am J Alzheimer Care Relat Disord Res.1990;5:22-25.
Warden VJ. Waste not, want not.  Geriatr Nurs.1989;10:210-211.
Frisoni GB, Franzoni S, Bellelli G, Morris J, Warden V. Overcoming eating difficulties in the severely demented. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer; 1998:48-67.
Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence.  JAMA.1999;282:1365-1370.
Meier DE, Ahronheim JC, Morris J, Baskin-Lyons S, Morrison RS. High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding.  Arch Intern Med.2001;161:594-599.
Ahronheim JC. Nutrition and hydration in the terminal patient.  Clin Geriatr Med.1996;12:379-391.
Teno JM, Mor V, DeSilva D, Kabumoto G, Roy J, Wetle T. Use of feeding tubes in nursing home residents with severe cognitive impairment [letter].  JAMA.2002;287:3211-3212.
Huang ZB, Ahronheim JC. Nutrition and hydration in terminally ill patients: an update.  Clin Geriatr Med.2000;16:313-315.
McCann R, Hall W, Groth-Juncker A. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration.  JAMA.1994;272:1263-1266.
Smith SJ. Providing palliative care for the terminal Alzheimer patient. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:247-256.
Rheaume EL, Brown J. Complexities of the grieving process in spouses of patients with Alzheimer's disease. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:189-204.
Pan CX, Meier DE. Clinical aspects of end-of-life care. In: Lawton MP, ed. Annual Review of Gerontology and Geriatrics. Focus on the End of Life: Scientific and Social Issues. New York, NY: Springer Publishing Co Inc; 2000:273-308.
Brown J, Lyon PC, Sellers TD. Caring for the family caregivers. In: Volicer L, Fabiszewski KJ, Rheaume YL, Lasch KE, eds. Clinical Management of Alzheimer's Disease. Rockville, Md: Royal Tunbridge: Aspen Publishers Inc; 1988:29-41.
Moss MS. End of life in nursing homes. In: Lawton MP, ed. Annual Review of Gerontology and Geriatrics. Focus on the End of Life: Scientific and Social Issues. New York, NY: Springer Publishing Co Inc; 2000:224-258.
Komaromy C, Sidell M, Katz JT. The quality of terminal care in residential and nursing homes.  Int J Palliat Nurs.2000;6:192-200.
Wolfson C, Wolfson DB, Asgharian M.  et al.  A reevaluation of the duration of survival after the onset of dementia.  N Engl J Med.2001;344:1111-1116.
Birks JS, Melzer D, Beppu H. Donepezil for mild and moderate Alzheimer's disease [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1997:issue 2.
Folstein M, Folstein S, McHugh PJ. "Mini-Mental State": a practical method for grading the cognitive state of patients for clinicians.  J Psychiatr Res.1975;12:189-198.
Not Available.  Reference Physician's Desk.  56th ed. Montvale, NJ: Medical Economics Co Inc; 2002.
Sano M, Ernesto C, Thomas RG.  et al.  A controlled trial of selegiline, alpa-tocopherol, or both as treatment for Alzheimer's disease.  N Engl J Med.1997;336:1216-1222.
Mulnard RA, Cotman CW, Kawas C.  et al.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.  JAMA.2000;283:1007-1015. [published correction appears in JAMA. 2000;284:2597].
Writing Group for the Women's Health Initiative Investigators.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.  JAMA.2002;288:321-333.
Hirata-Dulas CA, Stein DJ, Guay DR, Gruninger RP, Peterson PK. A randomized study of ciprofloxacin vs ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.  J Am Geriatr Soc.1991;39:1040-1041.
Ostbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia: a 5-year follow-up.  Neurology.1999;53:521-526.
Thompson RS, Hall NK, Szpiech M, Reisenberg LA. Treatments and outcomes of nursing-home-acquired pneumonia.  J Am Board Fam Pract.1997;10:82-87.
Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer.  J Am Geriatr Soc.1997;45:302-306.
Fabiszewski KJ, Volicer BJ, Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients.  JAMA.1990;263:3168-3172.
Luchins DJ, Hanrahan P, Murphy K. Criteria for enrolling dementia patients in hospice.  J Am Geriatr Soc.1997;45:1054-1059.
Kukull WA, Brenner DE, Speck CE.  et al.  Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death.  J Am Geriatr Soc.1994;42:723-726.
Hurley AC, Volicer BJ, Mahoney MA, Volicer L. Palliative fever management in Alzheimer patients: quality plus fiscal responsibility.  ANS Adv Nurs Sci.1993;16:21-32.
Hurley AC, Volicer B, Volicer L. Effect of fever management strategy on the progression of dementia of the Alzheimer type.  Alzheimer Dis Assoc Disord.1996;10:5-10.
Field MJ, Cassel CK. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997.
Parmelee PA, Smith B, Katz IR. Pain complaints and cognitive status among elderly institution residents.  J Am Geriatr Soc.1993;41:517-522.
Teno J, Weizman S, Wetle T, Mor V. Persistent pain in nursing home residents [letter].  JAMA.2001;285:2081.
Benedetti F, Vighetti S, Ricco C.  et al.  Pain threshold and tolerance in Alzheimer's disease.  Pain.1999;80:377-382.
Cook AK, Niven CA, Downs MG. Assessing the pain of people with cognitive impairment.  Int J Geriatr Psychiatry.1999;14:421-425.
Hurley AC, Volicer BJ, Hanrahan P, Houde S, Volicer L. Assessment of discomfort in advanced Alzheimer patients.  Res Nurs Health.1992;15:369-377.
Wilson SA, Kovach CR, Stearns SA. Hospice concepts in the care for end-stage dementia.  Geriatr Nurs.1996;17:6-10.
American Geriatric Society Panel on Persistent Pain in Older Persons.  The management of persistent pain in older persons.  J Am Geriatr Soc.2002;50(suppl):S205-S224.
Kovach CR, Weissman DE, Griffie J, Matson S, Muchka S. Assessment and treatment of discomfort for people with late-stage dementia.  J Pain Symptom Manage.1999;18:412-419.
Kovach CR, Noonan PE, Griffie J, Muchka S, Weissman DE. Use of the assessment of discomfort in dementia protocol.  Appl Nurs Res.2001;14:193-200.
Kovach CR. Effects of hospice interventions on nursing home residents with later stages of dementia. In: Volicer L, Hurley A, eds. Hospice Care for Patients With Advanced Progressive Dementia. New York, NY: Springer Publishing Co Inc; 1998:276-293.
Volicer L, Hurley A, Mahoney E. Psychopharmacology and late-stage dementia behaviors. In: Kovach CR, ed. Late-Stage Dementia Care: A Basic Guide. Bristol, Pa: Taylor & Francis; 1996:125-134.
Mahoney EK, Volicer L, Hurley AC. Management of Challenging Behaviors in Dementia. Baltimore, Md: Health Professions Press Inc; 2000.
Volicer L, Rheaume Y, Brown J, Fabiszewski KJ, Brady RJ. Hospice approach to the treatment of patients with advanced dementia of the Alzheimer type.  JAMA.1986;256:2210-2213.
Hanrahan P, Luchins DJ. Access to hospice care for end-stage dementia patients: a national survey of hospice programs.  J Am Geriatr Soc.1995;43:56-59.
Casarett D, Takesaka J, Karlawish J, Hirschman KB, Clark CM. How should clinicians discuss hospice for patients with dementia? anticipating caregivers' preconceptions and meeting their information needs.  Alzheimer Dis Assoc Disord.2002;16:116-122.
Volicer BJ, Hurley AC, Fabiszewski KJ, Montgomery P, Volicer L. Predicting short-term survival for patients with advanced Alzheimer's disease.  J Am Geriatr Soc.1993;41:535-540.
Stuart B, Herbst L, Kinbrunner B.  et al.  Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. Arlington, Va: National Hospice Organization; 1995.
Lynn J. Serving patients who may die soon and their families: the role of hospice and other services.  JAMA.2001;285:925-932.
Lynn J, Wilkinson A, Etherledge L. Financing of care for fatal chronic disease: opportunities for Medicare reform.  West J Med.2001;175:299-302.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario